Stemcells, Inc.

Get Full Access

Description

  • StemCells, Inc. is currently engaged in clinical development of its HuCNS-SC® platform technology (purified human neural stem cells) as a potential treatment for both neurological and retinal disorders. Top-line data from the Company's Phase I/II clinical trial in thoracic spinal cord injury (SCI) showed measurable gains involving multiple sensory modalities and segments, including the conversion of two of seven patients enrolled in the study with complete injuries to incomplete injuries, post-transplant. The Company's Pathway Study, a Phase II proof-of-concept trial in cervical SCI is actively enrolling at eight sites and interim data from the first cohort of six patients is anticipated to be forthcoming in Q4 2015. StemCells, Inc. has also completed its Phase I/II clinical trial in GA-AMD. Top-line results from this study show a positive safety profile and favorable preliminary efficacy data related to visual acuity and contrast sensitivity. The Company's Radiant Study, a Phase II proof-of-concept trial in GA-AMD is now enrolling at the first of approximately twenty U.S. sites expected to participate. In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, the Company showed preliminary evidence of progressive and durable donor-derived myelination by MRI.
  • location

    Headquarters:7707 Gateway Blvd Ste 140 Suite 140, Newark, California, United States

    More
  • Stemcells, Inc. phone

    Phone Number: +1 510-456-4100

  • Stemcells, Inc. website

    Website: https://www.stemcellsinc.com

  • Stemcells, Inc. employees

    Employees:56

  • Stemcells, Inc. revenue

    Revenue:$50 - 100M

  • Stemcells, Inc. legal name

    Legal Name:Stemcells, Inc.

  • Stemcells, Inc.'s Social Media

    Stemcells, Inc. linkedin Stemcells, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 621111  |

    Show More
Person level website identification

Chief Financial Officer for Stemcells, Inc.

Robert Thomas

Chief Financial Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Robert Thomas

Chief Financial Officer

Ferryadi Naibaho

Director Of Operations

Socheata Sing

Director, Qa

Sarah Thayer

Executive Director And Head, Clinical Operations

Sick Sicktom

Commercial Manager

Frequently Asked Questions regarding Stemcells, Inc.

  • Where are Stemcells, Inc.'s Headquarters?

    Stemcells, Inc.'s Headquarters are in 7707 Gateway Blvd Ste 140 Suite 140,Newark,California,United States

  • What is Stemcells, Inc.'s phone number?

    Stemcells, Inc.'s phone number is +1 510-456-4100

  • What is Stemcells, Inc.'s official website?

    Stemcells, Inc.'s official website is https://www.stemcellsinc.com

  • What is Stemcells, Inc.'s Revenue?

    Stemcells, Inc.'s revenue is $50 - 100M

  • What is Stemcells, Inc.'s NAICS code?

    Stemcells, Inc.'s NAICS code is 621111

  • How many employees are working in Stemcells, Inc.

    Stemcells, Inc. has 56 employees

  • What is Stemcells, Inc.'s Industry?

    Stemcells, Inc. is in the industry of Biotechnology

  • Who is Stemcells, Inc.'s Chief Financial Officer?

    Stemcells, Inc.'s Chief Financial Officer is Robert Thomas

Company Directory